New findings reveal the substantial burden of rare diseases due to lack of resources, financial challenges and emotional unrest Shire plc (LSE: SHP, NASDAQ: SHPG) have launched a Rare Disease Impact Report, which uncovers the health, psycho-social, and economic impact of rare diseases on patient and medical communities in the United States (US) and United Kingdom (UK)...
More...
More...